Critical care hasn’t had many breakthroughs in recent years and in order to change that, I believe we need to put more of an emphasis on integrating technology—specifically artificial intelligence (AI) —into the field.
Incorporating bioinformatics platforms can ease the burden of tracking, analyzing and managing the use of antibiotics.
The pace of innovation in the ICU is orders of magnitude slower than that of the cath lab and OR, and the COVID-19 crisis has pushed, tested, and exposed ICUs for lacking state-of-the-art technology and resources.
It is the first federal approval for a test that uses saliva as the primary test biomaterial for COVID-19.
Advanced Sterilization Products received an EUA for the STERRAD Sterilization Cycles.